Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Dolby Laboratories (DLB) stocks in Canada
Learn how to easily invest in Dolby Laboratories stocks.
Dolby Laboratories is an information technology services business based in the US. Dolby Laboratories stocks (DLB.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $98.36 – a decrease of 4.31% over the previous week. Dolby Laboratories employs 2,368 staff and has a trailing 12-month revenue of around $1.3 billion.
How to buy shares in Dolby Laboratories
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DLB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Dolby Laboratories?
- Has coronavirus impacted Dolby Laboratories shares?
- Dolby Laboratories shares summary
- Compare share dealing platforms
- Is Dolby Laboratories stock a buy or sell?
- Dolby Laboratories performance over time
- Are Dolby Laboratories shares over-valued?
- Dolby Laboratories's financials
- How volatile are Dolby Laboratories shares?
- Does Dolby Laboratories pay a dividend?
- Other common questions
Dolby Laboratories stock price (NYSE:DLB)Use our graph to track the performance of DLB stocks over time.
Dolby Laboratories shares at a glance
|Latest market close||$87.99|
|52-week range||$83.10 - $103.96|
|50-day moving average||$90.28|
|200-day moving average||$94.94|
|Wall St. target price||$112.67|
|Dividend yield||$0.91 (1.09%)|
|Earnings per share (TTM)||$2.97|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Dolby Laboratories stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Dolby Laboratories price performance over time
|1 week (2022-01-14)||-4.31%|
|1 month (2021-12-21)||-3.79%|
|3 months (2021-10-21)||-4.70%|
|6 months (2021-07-21)||-10.47%|
|1 year (2021-01-21)||-6.59%|
|2 years (2020-01-21)||27.76%|
|3 years (2019-01-18)||36.29%|
|5 years (2017-01-20)||79.57%|
Is Dolby Laboratories under- or over-valued?
Valuing Dolby Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dolby Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Dolby Laboratories's P/E ratio
Dolby Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Dolby Laboratories shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Dolby Laboratories's PEG ratio
Dolby Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4983. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Dolby Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Dolby Laboratories's EBITDA
Dolby Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $436.6 million.
The EBITDA is a measure of a Dolby Laboratories's overall financial performance and is widely used to measure a its profitability.
Dolby Laboratories financials
|Revenue TTM||$1.3 billion|
|Operating margin TTM||26.6%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||7.07%|
|Return on equity TTM||12.61%|
|Market capitalisation||$9.3 billion|
TTM: trailing 12 months
Dolby Laboratories share dividends
Dividend payout ratio: 24.73% of net profits
Recently Dolby Laboratories has paid out, on average, around 24.73% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.09% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Dolby Laboratories shareholders could enjoy a 1.09% return on their shares, in the form of dividend payments. In Dolby Laboratories's case, that would currently equate to about $0.91 per share.
While Dolby Laboratories's payout ratio might seem low, this can signify that Dolby Laboratories is investing more in its future growth.
Dolby Laboratories's most recent dividend payout was on 7 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 November 2021 (the "ex-dividend date").
Dolby Laboratories share price volatility
Over the last 12 months, Dolby Laboratories's shares have ranged in value from as little as $83.1 up to $103.9552. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Dolby Laboratories's is 0.9924. This would suggest that Dolby Laboratories's shares are less volatile than average (for this exchange).
Dolby Laboratories overview
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications. ; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment.
Stocks similar to Dolby Laboratories
Dolby Laboratories in the news
Earnings Preview: Dolby Laboratories (DLB) Q1 Earnings Expected to Decline
Netflix quietly admits streaming competition is eating into growth
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.